Health Care/Hospital

Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830

INCHEON, South Korea, Nov. 4, 2019 /PRNewswire/ -- Samsung Biologics announced the signing of a long-term agreement with Ichnos Sciences for manufacturing drug substance for ISB 830, an anti-OX40 monoclonal antibody in development as a potential treatment for moderate-to-severe atopic dermatitis....

2019-11-05 08:22 1120

Mum Hails $10 Childs Farm Skincare Products "Life-changing" After They Clear Her Daughter's Severe Eczema

"As a parent it's so frustrating not to be able to help your child when they're in need. I just felt so useless." BRISBANE, Australia, Nov. 5, 2019 /PRNewswire/ -- Tamika Hayley from Brisbane , says using theChilds Farm skincare range

2019-11-05 03:00 6652

Luye Pharma's LY03004 Manufacturing Facility Successfully Passes U.S. FDA Pre-approval Inspection with Zero Observation

SHANGHAI, Nov. 4, 2019 /PRNewswire/ -- LY03004, Luye Pharma's innovative, independently developed Extended-Release Microspheres for Injection has taken another step closer to going on the U.S. market. The company has announced that it has received the Establishment Inspection Report from the U.S....

2019-11-05 00:39 1143

Tencent and NEJM Yi Xue Qian Yan Host ME Summit to Promote Medical Science and Healthcare

BEIJING, Nov. 4, 2019 /PRNewswire/ -- Tencent Medipedia and NEJM Yi Xue Qian Yan, the Chinese version ofNew England Journal of Medicine, the world's leading medical journal and website under NEJM Group, jointly held the firstTencent Medical Enlightenment (ME) Summit inBeijing today. The Summit in...

2019-11-04 23:00 1645

China Biologic Products to Report Third Quarter 2019 Financial Results

BEIJING, Nov. 4, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its third quarter 2019 financial results o...

2019-11-04 21:30 8224

Toyobo and Saline Water Conversion Corporation sign MOU on joint pilot test aimed at accelerating use of new membrane technology for reusing concentrated brine

OSAKA, Japan, Nov. 1, 2019 /PRNewswire/ -- Toyobo Co., Ltd. has signed a memorandum of understanding (MOU) on joint pilot test with Saline Water Conversion Corporation (SWCC) to realize the practical application of a new brine concentration (BC) membrane technology that efficiently uses concentra...

2019-11-01 17:28 1156

Mallinckrodt and Terumo BCT Announce UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for the Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults

SYDNEY, Nov. 1, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, and Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, today announced that UVADEX®  (methoxsalen) has received regulatory approval inAustralia by th...

2019-11-01 04:35 6550

Icon Group Expands Cancer Care Capabilities with Purchase of Varian Adaptive Therapy Solution

PALO ALTO, California, Oct. 31, 2019 /PRNewswire/ -- Icon Group, Australia's largest dedicated provider of cancer care, with a growing reach intoNew Zealand andAsia, has made a purchase order to further improve the quality of cancer care treatment across its international network. The order inc...

2019-10-31 04:05 6630

Happiness Biotech Group Limited Announces Closing of US$11 Million Firm Commitment Initial Public Offering

NANPING, China, Oct. 30, 2019 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today the closing of previously announced a U.S. underwritten initial public offering ("Offering") of 2...

2019-10-31 02:30 6577

Presagen's AI Open Projects for clinics enables scalable unbiased AI medical products to be built from globally diverse datasets

SAN MATEO, Calif. and ADELAIDE, Australia, Oct. 30, 2019 /PRNewswire/ -- Presagen has launched a new AI product for clinics at the HLTH conference inLas Vegas, aimed at revolutionizing the way AI is applied to healthcare.   Presagen's AI Open Projects in an online platform that ...

2019-10-30 22:17 1099

Vivo Capital Closes $1.43 Billion Fund IX to Invest in Healthcare and Life Science Companies

PALO ALTO, California, Oct. 30, 2019 /PRNewswire/ -- Vivo Capital, a healthcare investment firm, announced the final closing of Vivo Capital Fund IX, L.P. (the "Fund") at$1.43 billion in committed capital from a broad group of existing and new global institutional investors. The firm plans to use...

2019-10-30 21:15 1238

GC Pharma Reports Q3 2019 Results

YONGIN, South Korea, Oct. 30, 2019 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months endedSeptember 30, 2019. Key Figures Q3 2019(1) Growth(1) Total revenues K...

2019-10-30 21:00 6336

Spectrum Therapeutics and Tree of Knowledge Announce Partnership to Educate and Support Healthcare Professionals

SMITHS FALLS, Ontario, Oct. 30, 2019 /PRNewswire/ -- Spectrum Therapeutics, the medical division of Canopy Growth Corporation ("Canopy Growth") (TSX:WEED) (NYSE: CGC) is pleased to announce that it has partnered with Tree of Knowledge International Corp. ("Tree of Knowledge") (CSE: TOKI) (OTC: TO...

2019-10-30 20:00 4482

World Pancreatic Cancer Day Campaign Launches to Raise Awareness of the Risks and Symptoms of the World's Toughest Cancer

More than 80 organizations from 30 countries to advocate for early diagnosis of pancreatic cancer onThursday, Nov. 21 MANHATTAN BEACH, California, Oct. 30, 2019 /PRNewswire/ -- Pancreatic cancer has the lowest survival rate among all major cancers because few people know the risks and symptoms a...

2019-10-30 05:47 856

WAT Medical will be returning to 2019 MEDICA to exhibit their innovative wearable technologies

VANCOUVER, British Columbia, Oct. 29, 2019 /PRNewswire/ -- From November 18-21, 2019, WAT Medical will be showcasing their EmeTerm, the anti-vomiting wristband, and HeadaTerm, the anti-migraine head patch, at one of the largest healthcare trade shows, MEDICA, inDusseldorf, Germany at Stand Hall 1...

2019-10-29 21:00 1654

Volition announces $500,000 in Non-Dilutive Funding for Volition Veterinary and issues Video

AUSTIN, Texas, Oct. 29, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the confirmation of a further$500,000 non-dilutive funding in the form of a loan from the Texas A&M SOFINEX funding agency of the Walloon Region to support the development of its sub...

2019-10-29 20:30 6315

Herbalife Nutrition Foundation Opens Six New Casa Herbalife Programs in Asia Pacific, Supporting Nutrition Programs for Children in Need

HONG KONG, Oct. 29, 2019 /PRNewswire/ -- Continuing its mission to improve communities around the world, the Herbalife Nutrition Foundation (HNF) has announced the addition of 29 new Casa Herbalife Nutrition programs in 20 countries around the globe. Of the 29 new programs, six are  based in theA...

2019-10-29 15:00 2151

Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis

- ADVISE clinical trial initiated and enrollment progressing - Evaluating patients with the clinical diagnosis of moderate-to-severe atopic dermatitis - Significant unmet need for an oral therapy in atopic dermatitis SAN DIEGO, Oct. 28, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ...

2019-10-28 20:30 3165

HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)

SINGAPORE, Oct. 26, 2019 /PRNewswire/ -- HistoIndex announces the expansion of its AI-based digital pathology platform towards large-scale NASH preclinical programs for pharmaceutical and biotech companies to achieve quantifiable and reproducible...

2019-10-26 19:00 1903

Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences

SAN FRANCISCO and SUZHOU, China, Oct. 26, 2019 /PRNewswire/ -- Adagene, Inc., a clinical stage biotech company with innovative antibody discovery and engineering technologies, announced that it is presenting its lead program at international conferences.  During the Festival of Biologics confere...

2019-10-26 18:01 1994